Ahead of our virtual panel discussion on the promises and pitfalls of precision medicine trials: now and in the future […]
A recent study has found that host factors seem to influence the disease outcomes in COVID-19 patients more than viral […]
Last week, we wrote a blog post on the benefits of integrating genomics into clinical trials, such as improved methods […]
Genomics has the potential to improve efficacy of drugs and accelerate precision healthcare, but one area with the biggest potential […]
“No decision about me, without me” was to be the new standard of thinking for a more patient-centric NHS future, […]
Singapore’s Health Sciences Authority has authorised clinical use of a new test for SARS-CoV-2 according to the Agency for Science, Technology, and Research (A*STAR).
Dr Watson is a HCPC registered Clinical Scientist leading NHS research and development activities in the Translational Genomics Unit (a […]
Alba studied Biochemistry and Biomedicine and did her PhD in Biotechnology at University of Valencia, Spain. She currently works at […]
Andrea Jorgensen is a Professor of Biostatistics at the University of Liverpool. She obtained an MSc with distinction in Medical […]
Karen Lighting Jones, Head of Future Place at Roche. Back in 2016, Dame Sally Davies concluded her Chief Medical Officer annual report by saying “Genomics is not tomorrow, it’s here today. I believe genomic services should be available to more patients, whilst being a cost-effective service in the NHS”.
